Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News (Page 12)
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
Social Life Protects From Stroke, Infections, Blood Proteins Suggest
MONDAY, Jan. 6, 2025 – Palling around with family and friends is more than just fun and relaxing – it also boosts health. A new study published in the journal Nature Human Behavior says that blood...
Adults Screened for Inactivity Have Lower Rates of Comorbid Conditions
THURSDAY, Jan. 2, 2025 – Adults screened for inactivity at well visits have lower rates of comorbid conditions, according to a study published online Jan. 2 in Preventing Chronic Disease. Cole G....
Late Eating Tied to Poor Glucose Tolerance
THURSDAY, Jan. 2, 2025 – Late consumption of calories is associated with worse glucose tolerance, according to a study published online Oct. 25 in Nutrition & Diabetes. Diana A. Díaz-Rizzolo, Ph.D., ...
How do GLP-1s Boost Weight Loss, Heart Health?
THURSDAY, Jan. 2, 2024 – Weight loss tops many folks’ list of New Years resolutions, and lots of people are turning to cutting-edge weight-loss drugs like Ozempic to help them drop excess pounds. T...
FDA Approves First Generic Liraglutide Once-Daily Injection
THURSDAY, Dec. 26, 2024 – The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), a glucagon-like peptide-1 (GLP-1) receptor...
FDA Approves Generic GLP-1 Medicine, Liraglutide, (a Victoza Generic), For Diabetes Treatment
THURSDAY, Dec. 26, (2024 HealthDay News) – The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for people ...
FDA Approves First Generic of GLP-1 Receptor Agonist Victoza (liraglutide injection) to Lower Blood Sugar in Patients with Type 2 Diabetes
December 23, 2024 – Today, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1)...
High Acceptance Seen for Liver Stiffness Test With Routine Retina Scan in T2DM
FRIDAY, Dec. 20, 2024 – For individuals with type 2 diabetes, examination with vibration-controlled transient elastography (VCTE) alongside retina scanning has a high acceptance rate, but...
FDA Says Shortage of GLP-1 Tirzepatide (Mounjaro, Zepbound) Is Over
THURSDAY, Dec. 19, 2024 – The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication tirzepatide is over....
Empagliflozin Not Tied to Risk for New Nonproliferative Diabetic Retinopathy
TUESDAY, Dec. 17, 2024 – Empagliflozin initiation is not associated with incident nonproliferative diabetic retinopathy (NPDR) compared with initiation of a dipeptidyl peptidase 4 inhibitor (DPP4i),...
Artificial Sweetener Use Tied to Less-Healthy Diets
WEDNESDAY, Dec. 18, 2024 – Folks who switch to artificial sweeteners in drinks and food may be drawn to other types of unhealthy fare – bringing down the quality of their overall diet, new research...
Layperson-Delivered Empathetic Intervention Ups Glycemic Control
FRIDAY, Dec. 13, 2024 – A telephone-based layperson-delivered empathetic engagement is beneficial for improving glycemic control in patients with diabetes with low income, according to a study...
Blood Test Might Help Doctors Spot Multiple Diseases
THURSDAY, Dec. 12, 2024 – A blood draw is a typical part of a person's regular check-up. But that blood sample might hold a lot more useful information about a person’s health than doctors are c...
Weaker Handgrip Strength Tied to Higher Likelihood of Diabetes
WEDNESDAY, Dec. 11, 2024 – Weaker handgrip strength (HGS) appears to be associated with a higher likelihood of having diabetes mellitus (DM) among postmenopausal women, according to a study...
Vitamin D Supplementation Does Not Reduce Risk for T2DM in Healthy Seniors
TUESDAY, Dec. 10, 2024 – Vitamin D3 supplementation does not significantly reduce the risk for developing diabetes among older adults who are not at high risk for diabetes, according to a study...
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Mounjaro, Victoza, Lantus, semaglutide, Trulicity, glipizide, Rybelsus, view more... tirzepatide, Jardiance, liraglutide, Lantus Solostar, Humalog, Farxiga, Novolog, Janumet, insulin glargine, Januvia, Bydureon, insulin lispro, Tresiba, dulaglutide, Levemir, insulin degludec, Invokana, glimepiride, Glucophage, Humulin N